Improving Endometrial Cancer Assessment by Combining Genomic Profiling and Surgical Assessment
Recruiting
N/A
Interventional Study
Endometrial Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 1,000 (estimated)
- Sponsor
- University Hospital, Gasthuisberg · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
EUGENIE is a prospective multicentre interventional study, focused on improving endometrial cancer (EC) assessment by combining the new technique of genomic profiling with surgical extra uterine disease assessment. The investigators aim to correlate EC stage to each of the molecular subgroups of disease and thereby guide surgical treatment and staging of EC by determining the association between m…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Voluntary written informed consent of the participant or their legally authorized representative has been obtained before any screening procedures
* Women ≥ 18 years
* First diagnosis of EC, all disease stages and all histo-types
Exclusion Criteria:
* Participant has a histo…
Contacts